The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy
NCT02905916
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
217
Enrollment
OTHER
Sponsor class
Conditions
Mammary Cancer
Lymphoma
Bone Tumour
Gynecological Tumors
Interventions
DRUG:
PEG-rhG-CSF
Sponsor
Peking University